Skip to main content
. 2026 Nov 9;18(21):3592. doi: 10.3390/cancers18213592
AI Artificial intelligence
ABVD Adriamycin (doxorubicin), Bleomycin, Vinblastine, Dacarbazine
A-HIPI Advanced-stage Hodgkin Lymphoma International Prognostic Index
ASCT Autologous stem-cell transplantation
cHL Classic Hodgkin lymphoma
ctDNA Circulating tumor DNA
EBV Epstein–Barr virus
GVD Gemcitabine, vinorelbine, liposomal doxorubicin
HRS Hodgkin and Reed–Sternberg
ICC International Consensus Classification
IPS International Prognostic Score
LMP1 Latent membrane protein 1
MDSC Myeloid-derived suppressor cell
MRD Minimal residual disease
MTAP Methylthioadenosine phosphorylase
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
NMF Non-negative matrix factorization
PD-1 Programmed cell death protein 1
PD-L1 Programmed death-ligand 1
PFS Progression-free survival
TAMs Tumor-associated macrophages
TARC Thymus and Activation-Regulated Chemokine
TMTV Total metabolic tumor volume
TME Tumor microenvironment
Tpex Progenitor exhausted T cells
Tregs Regulatory T cells
WHO World Health Organization